Testing effectiveness (Phase 2)Active Not RecruitingNCT03598309
What this trial is testing
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Who this might be right for
Lung DiseasesLung Cancer, Protection Against
H. Lee Moffitt Cancer Center and Research Institute 19